The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 339:774-775 September 10, 1998 Number 11
NextNext

Role of Fecal Occult-Blood Testing

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Simon, J. B.
-PubMed Citation
To the Editor: Simon's argument against population screening for colorectal cancer by fecal occult-blood testing (April 16 issue)1 contains inaccurate conclusions related to our Minnesota screening trial.2 First, he concludes that the fecal occult-blood test has limited sensitivity. An analysis of the sensitivity of individual screening tests and of repetitive screening in our trial shows that of the cases detected among subjects in compliance with the requirements of the test, only about 10 percent were missed at the time of the screening.3 Although only half the cancers diagnosed during the trial were detected by screening, only about 50 percent of . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.